The Journal of Urology
Volume 183, Issue 2 , Pages 455-459 , February 2010

Effect of Reclassification on the Incidence of Benign and Malignant Renal Tumors

  • Ted A. Skolarus

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • Corresponding Author InformationCorrespondence: Division of Urologic Surgery, Washington University in St. Louis, 4960 Children's Place, Box 8242, St. Louis, Missouri 63110 (telephone: 314-362-8212)
    • ,
  • Maria F. Serrano

      Affiliations

    • Department of Pathology and Immunology, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • ,
  • Robert L. Grubb III

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Alvin J. Siteman Cancer Center, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Financial interest and/or other relationship with GlaxoSmithKline and the National Cancer Institute–PLCO Cancer Screening Trial.
    • ,
  • Matthew D. Katz

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • ,
  • Travis L. Bullock

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Financial interest and/or other relationship with Astellas.
    • ,
  • Feng Gao

      Affiliations

    • Division of Biostatistics, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Alvin J. Siteman Cancer Center, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • ,
  • Peter A. Humphrey

      Affiliations

    • Department of Pathology and Immunology, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Alvin J. Siteman Cancer Center, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Nothing to disclose.
    • ,
  • Adam S. Kibel

      Affiliations

    • Division of Urologic Surgery, Department of Surgery, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Alvin J. Siteman Cancer Center, Washington University School of Medicine and Barnes Jewish Hospital, St. Louis, Missouri
    • Financial interest and/or other relationship with Sanofi-Aventis, Envisioneering Medical Technologies, Wilex, Ortho-McNeil Phramaceutical and AstraZeneca.

Received 10 June 2009

References 

  1. Chow WH, Devesa SS, Warren JL, et al. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628
  2. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology. 1998;51:203
  3. Miller DC, Hollingsworth JM, Hafez KS, et al. Partial nephrectomy for small renal masses: an emerging quality of care concern?. J Urol. 2006;175:853
  4. Huynh PN, Hollander JB. Trends toward laparoscopic nephrectomy at a community hospital. J Urol. 2005;173:547
  5. Scherr DS, Ng C, Munver R, et al. Practice patterns among urologic surgeons treating localized renal cell carcinoma in the laparoscopic age: technology versus oncology. Urology. 2003;62:1007
  6. Clayman RV, Kavoussi LR, Soper NJ, et al. Laparoscopic nephrectomy: initial case report. J Urol. 1991;146:278
  7. Bhayani SB, Clayman RV, Sundaram CP, et al. Surgical treatment of renal neoplasia: evolving toward a laparoscopic standard of care. Urology. 2003;62:821
  8. Aron M, Gill IS. Minimally invasive nephron-sparing surgery (MINSS) for renal tumours part I: laparoscopic partial nephrectomy. Eur Urol. 2007;51:337
  9. Hollingsworth JM, Miller DC, Daignault S, et al. Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst. 2006;98:1331
  10. Schlomer B, Figenshau RS, Yan Y, et al. Pathological features of renal neoplasms classified by size and symptomatology. J Urol. 2006;176:1317
  11. Tsui KH, Shvarts O, Smith RB, et al. Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol. 2000;163:426
  12. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; 2004;
  13. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumours. J Pathol. 1997;183:131
  14. Lopez-Beltran A, Scarpelli M, Montironi R, et al. 2004 WHO classification of the renal tumors of the adults. Eur Urol. 2006;49:798
  15. Hollingsworth JM, Miller DC, Daignault S, et al. Variable penetrance of a consensus classification scheme for renal cell carcinoma. Urology. 2007;69:452
  16. Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19:335
  17. Jewett MA, Zuniga A. Renal tumor natural history: the rationale and role for active surveillance. Urol Clin North Am. 2008;35:627
  18. Volpe A, Mattar K, Finelli A, et al. Contemporary results of percutaneous biopsy of 100 small renal masses: a single center experience. J Urol. 2008;180:2333
  19. Amin MB, Paner GP, Alvarado-Cabrero I, et al. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol. 2008;32:1822
  20. Frank I, Blute ML, Cheville JC, et al. Solid renal tumors: an analysis of pathological features related to tumor size. J Urol. 2003;170:2217
  21. Kashgarian M, Rosai J. Kidney, renal pelvis and ureter. In:  Rosai J editors. Ackerman's Surgical Pathology. 7th ed.. St. Louis: CV Mosby Company; 1989;p. 875
  22. Kümmerlin I, ten Kate F, Smedts F, et al. Diagnostic problems in the subtyping of renal tumors encountered by five pathologists. Pathol Res Pract. 2009;205:27
  23. Lane BR, Samplaski MK, Herts BR, et al. Renal mass biopsy–a renaissance?. J Urol. 2008;179:20
  24. Vasudevan A, Davies RJ, Shannon BA, et al. Incidental renal tumours: the frequency of benign lesions and the role of preoperative core biopsy. BJU Int. 2006;97:946
  25. Choudhary S, Rajesh A, Mayer NJ, et al. Renal oncocytoma: CT features cannot reliably distinguish oncocytoma from other renal neoplasms. Clin Radiol. 2009;64:517

 Study received institutional review board approval.

 Editor's Note: This article is the second of 5 published in this issue for which category 1 CME credits can be earned. Instructions for obtaining credits are given with the questions on pages 834 and 835.

PII: S0022-5347(09)02703-7

doi: 10.1016/j.juro.2009.10.045

The Journal of Urology
Volume 183, Issue 2 , Pages 455-459 , February 2010

Article Tools

* Image Usage & Resolution